Company Filing History:
2 out of 517 
1 out of 80 
1 out of 1 Years Active: 1997-2000
Title: Kirk R Daffner: Innovator in Non-Invasive Alzheimer's Diagnosis
Introduction
Kirk R Daffner is a notable inventor based in Newton, MA (US), recognized for his contributions to medical technology. He holds four patents, with a focus on non-invasive methods for diagnosing Alzheimer's disease. His innovative approaches aim to improve the accuracy and efficiency of Alzheimer's diagnosis, benefiting both patients and healthcare providers.
Latest Patents
Daffner's latest patents include a non-invasive method for diagnosing Alzheimer's disease in a patient. This invention provides techniques that utilize an automated apparatus to continuously monitor pupil diameter size over time. The method involves repetitively measuring pupil diameter for a duration ranging from less than one second to five minutes, cumulatively recording the size information as it is obtained. Additionally, a second method measures pupil constriction velocity before and after stimulation by visible light. Both methods require administering a neural transmitter mediator to the targeted eye of the subject in an amount that does not cause significant changes in pupil diameter for individuals not afflicted with Alzheimer's disease. The heightened sensitivity of Alzheimer's patients to the administered mediator serves as a means for identifying those affected by the disease.
Career Highlights
Throughout his career, Daffner has worked with reputable organizations, including Beth Israel Deaconess Medical Center and The Beth Israel Hospital Association. His experience in these institutions has contributed to his expertise in medical research and innovation.
Collaborations
Daffner has collaborated with notable colleagues, including Leonard Scinto and Leonard F Scinto, enhancing his research and development efforts in the field of Alzheimer's diagnosis.
Conclusion
Kirk R Daffner's work in developing non-invasive diagnostic methods for Alzheimer's disease showcases his commitment to advancing medical technology. His innovative patents reflect a significant contribution to the healthcare industry, aiming to improve patient outcomes and diagnostic accuracy.